Mononuclear phagocyte–specific cGAS/STING targeting suppresses experimental choroidal neovascularization
JCI Insight · 10.08.2026 · 11 (15)
DOI: 10.1172/jci.insight.203452 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 10.08.2026. Verfasst von Le Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Membrane Proteins, Nucleotidyltransferases. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health, National Institutes of Health core grant.
Abstract (Originalsprache)
Neovascular age-related macular degeneration (nAMD) is a major cause of blindness and is characterized by pathologic angiogenesis, specifically choroidal neovascularization (CNV). Mononuclear phagocytes (MPs), including infiltrating systemic monocyte-derived macrophages and retinal microglia, play critical roles in promoting CNV. The cGAS/STING pathway is increasingly implicated in multiple neuronal and systemic diseases and recently in ocular neovascularization. Given its roles across multiple cell types and the absence of MP-targeted therapies, we investigated the MP-specific role of cGAS/STING and a strategy for its selective targeting. In the laser-induced CNV mouse model, cGAS/STING was predominantly expressed in MPs. To enable selective targeting, we used a hydroxyl dendrimer (HD) previously shown to target MPs. HD conjugated to Cy3 selectively localized to MPs in laser CNV. HD conjugated to the STING inhibitor SN-011 (HD-SN-011) effectively inhibited cGAS/STING activation in cultured MPs. In the laser-CNV model, HD-SN-011 significantly reduced CNV leakage and lesion size, both important clinical endpoints in nAMD. RiboTag profiling confirmed selective suppression of cGAS/STING signaling and inflammatory gene expression in MPs. Together, our results implicate the specific importance of MP cGAS/STING signaling in CNV and provide proof of concept for specific modulation of STING in MPs as a therapy for nAMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Förderung
- NEI NIH HHS
- National Institutes of Health
- National Institutes of Health core grant
- the Altsheler-Durell Foundation
- Arnall Patz Distinguished Professorship
- RPB Unrestricted Grant
Zitieren
APA
Shi, L., Cherukaraveedu, D., Cho, H., Ri, K., Zhou, L., Cao, Y., Kale, N., Xu, Z., Liyanage, W., Kannan, R. M., & Duh, E. J. (2026). Mononuclear phagocyte–specific cGAS/STING targeting suppresses experimental choroidal neovascularization. JCI Insight, 11(15). https://doi.org/10.1172/jci.insight.203452
Vancouver
Shi L, Cherukaraveedu D, Cho H, Ri K, Zhou L, Cao Y, et al. Mononuclear phagocyte–specific cGAS/STING targeting suppresses experimental choroidal neovascularization. JCI Insight. 2026;11(15). doi:10.1172/jci.insight.203452
BibTeX
@article{Shi2026,
author = {Shi, Le and Cherukaraveedu, Durgadas and Cho, Hongkwan and Ri, Kaoru and Zhou, Lingli and Cao, Yingxue and Kale, Narendra and Xu, Zhenhua and Liyanage, Wathsala and Kannan, Rangaramanujam M and Duh, Elia J},
title = {Mononuclear phagocyte–specific cGAS/STING targeting suppresses experimental choroidal neovascularization},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {15},
doi = {10.1172/jci.insight.203452}
}
EUVIMED